retatrutide triple agonist gip glp-1 glucagon phase 3 2025 Mounjaro: and Diabetes Dual and Triple Gut Peptide
Description
It transforms guesswork into data-driven decisions
A bathroom counter works
Two shakes daily combined with protein-focused meals makes hitting targets achievable
A 2024 study from Epic Research found that people with hypothyroidism who lost more than 5 pounds while taking GLP-1 medications (including semaglutide) saw TSH (thyroid-stimulating hormone) levels decrease by an average of about 0.55 mU/L
